Whitehawk Therapeutics, Inc. (3350)

Profile

https://ir.whitehawktx.com

Whitehawk Therapeutics, Inc. is a clinical-stage oncology therapeutics company focused on developing antibody-drug conjugate (ADC) cancer treatments. Its current portfolio centers on three ADC assets designed to target clinically validated proteins across multiple tumor types, with emphasis on difficult-to-treat cancers. The company applies advanced technologies to tumor biology to support the development of more precise cancer therapies and to address limitations associated with earlier ADC approaches. Whitehawk Therapeutics works in the biotechnology sector and serves the broader oncology market through its research and development programs aimed at genetically and biologically defined cancers. Headquartered in Morristown, New Jersey, Whitehawk Therapeutics is positioned as a specialized drug development company centered on targeted cancer treatment innovation.